je.st
news
Tag: for
Ferrari valued at almost US$10 billion for IPO
2015-10-12 00:11:45| Automakers - Topix.net
Fiat Chrysler Automobiles is planning a U.S. stock debut for Ferrari that values the luxury Italian sports carmaker at nearly US$10 billion, according to a filing with U.S. regulators Friday. Ferrari, of the famed "prancing stallion" logo, will make its first steps on Wall Street, expected in late October, after years of rumors.
Tags: for
billion
ferrari
valued
Once A Batman Girl; Can Katie Holmes Be Cover Girl For NJ Transit?
2015-10-09 20:11:27| Railroads - Topix.net
Katie Holmes could have a future as a New Jersey Transit cover girl - whether her movie career gets rolling again or not. Holmes posted a photo of herself on Instagram this past week wearing a red ballgown and boarding a NJ Transit train at Penn Station in New York City, according to nj.com.
ET deals: Dell Inspiron 15 7000 series quad-core gaming laptop for $849
2015-10-09 16:01:55| Extremetech
If you're looking for a reasonably priced gaming laptop that can still handle the major new releases, take a look at the 15.6-inch Inspiron 15 7000 series from Dell. With a brand new quad-core Skylake processor, a graphics card with some real horsepower, and a solid state hybrid drive, this laptop can hold its own at any LAN party. And at a $250.99 discount, the value proposition here is outstanding.
KEYTRUDA (pembrolizumab) Receives New Draft Recommendation from National Institute for Health and Care Excellence (NICE) in U.K. for First-Line Treatment for Advanced Melanoma
2015-10-09 13:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KEYTRUDA is Currently Approved in 39 Countries, including the United States and throughout the European Union KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the National Institute for Health and Care Excellence (NICE) of the United Kingdom (U.K.) has issued a draft recommendation, in the form of a Final Appraisal Determination (FAD), recommending KEYTRUDA (pembrolizumab) as a first-line treatment option for adults with advanced melanoma. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orAn Phan, 908-236-1130orInvestors:Teri Loxam, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: for
advanced
health
care
Google Releases Public Transportation App ... But Just for India
2015-10-08 23:02:33| PC Magazine Software Product Guide
The app offers schedules and directions and you don't even need an internet connection to get this info.
Sites : [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] next »